{"id":68819,"date":"2021-06-12T08:21:34","date_gmt":"2021-06-12T12:21:34","guid":{"rendered":"http:\/\/stateofthenation.co\/?p=68819"},"modified":"2021-06-12T08:21:34","modified_gmt":"2021-06-12T12:21:34","slug":"these-are-some-of-the-bravest-covid-physicians-in-the-usa","status":"publish","type":"post","link":"https:\/\/stateofthenation.co\/?p=68819","title":{"rendered":"These are some of the BRAVEST Covid Physicians in the USA"},"content":{"rendered":"

<\/p>\n

The FLCCC Physicians<\/h1>\n
\n
\n
\n
\n
\n

How the FLCCC Alliance came together and developed effective treatment protocols for COVID-19\u00a0<\/strong>(March 10, 2021)<\/p>\n

This is the story about how the FLCCC Alliance was formed\u2014and how, at the start of the pandemic, the team quickly began to develop protocols to successfully treat patients. Their first protocol was the MATH+ Hospital Treatment Protocol that was used to save critically ill patients and to prevent them from having to rely on ventilators to breathe.<\/p>\n

Subsequently, as COVID-19 cases surged, they urgently researched ways to offload the hospitals and reduce case counts and deaths. The team developed the I-MASK+ Prevention & Early Outpatient Treatment Protocol\u2014centered around the drug ivermectin\u2014which is effective for every phase of COVID-19 disease\u2026 from prevention through late phase illness.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n

The Front Line Covid-19 Critical Care Alliance was created by highly published critical care specialists from major academic medical centers with collectively over 1,000 medical publications. Based on the rapidly emerging research into COVID-19, the early clinical experience in China reflected by the Shanghai expert commission, and their decades-long clinical and research experiences in severe infectious diseases around the country, the 5 experts developed the\u00a0<\/i>\u00a0MATH+ Hospital Treatment Protocol for Covid-19<\/a>. It is intended\u00a0for use early in the hospitalization of patients presenting with states of respiratory distress requiring supplemental oxygen. In October 2020, after reviewing numerous new studies from around the world on the antiparasitic drug ivermectin\u2019s use in prophyaxis and all stages of treatment for COVID-19, the team created the\u00a0<\/i>\u00a0I-MASK+ protocol for prevention and early outpatient treatment<\/a>.\u00a0These 5 physicians have since been joined by an increasing number of hospitalist and ICU physicians who recognize the sound physiologic rationale, the emerging published research in support of the components, and the data demonstrating good clinical outcomes in hospitals and communities that have adopted the treatment regimen.<\/span><\/p>\n<\/div>\n<\/div>\n

<\/div>\n

Founding members \/ MATH+ and I-MASK+ developers<\/h3>\n
\n
<\/div>\n<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\"Paul<\/figure>\n<\/div>\n
\n

Paul E. Marik, M.D., FCCM, FCCP<\/h2>\n<\/div>\n
\n
\n